Differential Inhibition of Adenylylated and Deadenylylated Forms of M. Tuberculosis Glutamine Synthetase As a Drug Discovery Platform

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Oct 4

PMID 28972974

Citations 4

Authors

A Theron

R L Roth

H Hoppe

C Parkinson

C W van der Westhuyzen

S Stoychev

I Wiid

R D Pietersen

B Baker

C P Kenyon

Affiliations

Soon will be listed here.

Abstract

Glutamine synthetase is a ubiquitous central enzyme in nitrogen metabolism that is controlled by up to four regulatory mechanisms, including adenylylation of some or all of the twelve subunits by adenylyl transferase. It is considered a potential therapeutic target for the treatment of tuberculosis, being essential for the growth of Mycobacterium tuberculosis, and is found extracellularly only in the pathogenic Mycobacterium strains. Human glutamine synthetase is not regulated by the adenylylation mechanism, so the adenylylated form of bacterial glutamine synthetase is of particular interest. Previously published reports show that, when M. tuberculosis glutamine synthetase is expressed in Escherichia coli, the E. coli adenylyl transferase does not optimally adenylylate the M. tuberculosis glutamine synthetase. Here, we demonstrate the production of soluble adenylylated M. tuberulosis glutamine synthetase in E. coli by the co-expression of M. tuberculosis glutamine synthetase and M. tuberculosis adenylyl transferase. The differential inhibition of adenylylated M. tuberulosis glutamine synthetase and deadenylylated M. tuberulosis glutamine synthetase by ATP based scaffold inhibitors are reported. Compounds selected on the basis of their enzyme inhibition were also shown to inhibit M. tuberculosis in the BACTEC 460TB™ assay as well as the intracellular inhibition of M. tuberculosis in a mouse bone-marrow derived macrophage assay.

Citing Articles

Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery.

Guida M, Tammaro C, Quaranta M, Salvucci B, Biava M, Poce G Pharmaceutics. 2024; 16(6).

PMID: 38931847 PMC: 11206623. DOI: 10.3390/pharmaceutics16060725.

Distinct evolution of type I glutamine synthetase in Plasmodium and its species-specific requirement.

Ghosh S, Kundu R, Chandana M, Das R, Anand A, Beura S Nat Commun. 2023; 14(1):4216.

PMID: 37452051 PMC: 10349072. DOI: 10.1038/s41467-023-39670-4.

An Intrinsic Alkalization Circuit Turns on Riboswitch under Manganese Stress in Escherichia coli.

Kalita A, Mishra R, Kumar V, Arora A, Dutta D Microbiol Spectr. 2022; 10(5):e0336822.

PMID: 36190429 PMC: 9603457. DOI: 10.1128/spectrum.03368-22.

Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of to bedaquiline.

Wang Z, Soni V, Marriner G, Kaneko T, Boshoff H, Barry 3rd C Proc Natl Acad Sci U S A. 2019; 116(39):19646-19651.

PMID: 31501323 PMC: 6765305. DOI: 10.1073/pnas.1907946116.

References

Mecke D, Wulff K, Liess K, Holzer H . Characterization of a glutamine synthetase inactivating enzyme from Escherichia coli. Biochem Biophys Res Commun. 1966; 24(3):452-8. DOI: 10.1016/0006-291x(66)90182-3. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Kenyon C, Steyn A, Roth R, Steenkamp P, Nkosi T, Oldfield L . The role of the C8 proton of ATP in the regulation of phosphoryl transfer within kinases and synthetases. BMC Biochem. 2011; 12:36. PMC: 3145573. DOI: 10.1186/1471-2091-12-36. View

Brown J, Masuchi Y, Robb F, Doolittle W . Evolutionary relationships of bacterial and archaeal glutamine synthetase genes. J Mol Evol. 1994; 38(6):566-76. DOI: 10.1007/BF00175876. View

Backman K, Chen Y, MAGASANIK B . Physical and genetic characterization of the glnA--glnG region of the Escherichia coli chromosome. Proc Natl Acad Sci U S A. 1981; 78(6):3743-7. PMC: 319648. DOI: 10.1073/pnas.78.6.3743. View

Holzer H, Schutt H, Masek Z, Mecke D . Regulation of two forms of glutamine synthetase in Escherichia coli by the ammonia content of the growth medium. Proc Natl Acad Sci U S A. 1968; 60(2):721-4. PMC: 225105. DOI: 10.1073/pnas.60.2.721. View

Gising J, Nilsson M, Odell L, Yahiaoui S, Lindh M, Iyer H . Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitors. J Med Chem. 2012; 55(6):2894-8. PMC: 3381009. DOI: 10.1021/jm201212h. View

Nilsson M, Krajewski W, Yellagunda S, Prabhumurthy S, Chamarahally G, Siddamadappa C . Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors. J Mol Biol. 2009; 393(2):504-13. DOI: 10.1016/j.jmb.2009.08.028. View

Mehta R, Pearson J, Mahajan S, Nath A, Hickey M, Sherman D . Adenylylation and catalytic properties of Mycobacterium tuberculosis glutamine synthetase expressed in Escherichia coli versus mycobacteria. J Biol Chem. 2004; 279(21):22477-82. DOI: 10.1074/jbc.M401652200. View

10.

Odell L, Nilsson M, Gising J, Lagerlund O, Muthas D, Nordqvist A . Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors. Bioorg Med Chem Lett. 2009; 19(16):4790-3. DOI: 10.1016/j.bmcl.2009.06.045. View

11.

Couturier C, Silve S, Morales R, Pessegue B, Llopart S, Nair A . Nanomolar inhibitors of Mycobacterium tuberculosis glutamine synthetase 1: synthesis, biological evaluation and X-ray crystallographic studies. Bioorg Med Chem Lett. 2015; 25(7):1455-9. DOI: 10.1016/j.bmcl.2015.02.035. View

12.

Harth G, Horwitz M . An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med. 1999; 189(9):1425-36. PMC: 2193054. DOI: 10.1084/jem.189.9.1425. View

13.

Kingdon H, SHAPIRO B, Stadtman E . Regulation of glutamine synthetase. 8. ATP: glutamine synthetase adenylyltransferase, an enzyme that catalyzes alterations in the regulatory properties of glutamine synthetase. Proc Natl Acad Sci U S A. 1967; 58(4):1703-10. PMC: 223983. DOI: 10.1073/pnas.58.4.1703. View

14.

Gaillardin C, MAGASANIK B . Involvement of the product of the glnF gene in the autogenous regulation of glutamine synthetase formation in Klebsiella aerogenes. J Bacteriol. 1978; 133(3):1329-38. PMC: 222170. DOI: 10.1128/jb.133.3.1329-1338.1978. View

15.

Bender R, Janssen K, Resnick A, Blumenberg M, Foor F, MAGASANIK B . Biochemical parameters of glutamine synthetase from Klebsiella aerogenes. J Bacteriol. 1977; 129(2):1001-9. PMC: 235040. DOI: 10.1128/jb.129.2.1001-1009.1977. View

16.

SHAPIRO B, Stadtman E . 5'-adenylyl-O-tyrosine. The novel phosphodiester residue of adenylylated glutamine synthetase from Escherichia coli. J Biol Chem. 1968; 243(13):3769-71. View

17.

Tyler B . Regulation of the assimilation of nitrogen compounds. Annu Rev Biochem. 1978; 47:1127-62. DOI: 10.1146/annurev.bi.47.070178.005403. View

18.

Raynaud C, Etienne G, Peyron P, Laneelle M, Daffe M . Extracellular enzyme activities potentially involved in the pathogenicity of Mycobacterium tuberculosis. Microbiology (Reading). 1998; 144 ( Pt 2):577-587. DOI: 10.1099/00221287-144-2-577. View

19.

Johnson R, Warren R, Van der Spuy G, Gey van Pittius N, Theron D, Streicher E . Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int J Tuberc Lung Dis. 2009; 14(1):119-21. View

20.

SHAPIRO B, Kingdon H, Stadtman E . Regulation of glutamine synthetase. VII. Adenylyl glutamine synthetase: a new form of the enzyme with altered regulatory and kinetic properties. Proc Natl Acad Sci U S A. 1967; 58(2):642-9. PMC: 335683. DOI: 10.1073/pnas.58.2.642. View